和鉑醫藥控股有限公司（股票代號：2142）于2025年12月31日公布翌日披露報表，披露回购股份及已发行股本变动等事项。
根据公告，2025年12月31日公司在香港联交所回购股份共计100,000股，占回购前已发行股本的约0.0115%。回购价格介乎每股12.12港元至12.29港元，总共支付约121.94万港元。完成后，公司已发行股份（不包括库藏股）为868,681,522股，库藏股数增至25,437,000股，总股本达到894,163,522股。
回购授权于2025年6月11日获股东大会批准，授权回购总数为82,834,612股。截至本次回购，累计回购7,100,000股，约占授权时已发行股本的0.857%。公司在公告中确认，本次回购事宜及相关程序已遵守上市规则与适用法律规定。
本公告由执行董事王劲松签署。公司强调，将继续按照法规要求履行披露责任，并做好后续相关信息发布。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.